The Pfizer Papers, page 8
Vascular
As cases accrue, the number of organs is expected to increase.
Table 5: Histopathology: Mechanisms of Injury
Histology Definition
Apoptosis Cell Death
Coagulopathy Clotting
Infarction Sudden Loss of Blood Supply
Infiltration Abnormal Accumulation
Inflammation Complex Chemical and Cellular Cascade that clears debris, microbes and begins Repair
Lysis Dissolution
Necrosis Death
Neoplasia Pre Cancer or Cancer
Autopsy, Histopathology and Determination of Cause of Death Case Report:
Hunter Brown, Age 21
“I’m heartbroken that I’ll never see him on the football field again, graduate from the Academy, establish a career, get married, or have kids,” she wrote. “He was my joy and I loved being his mom. I was so proud of the man he had become. We are so thankful for all the support and prayers we have received, they have definitely eased some of the pain. Please continue to pray for our family.”
(https://taskandpurpose.com/news/air-force-academy-cadet-dies/)
“A coroner has determined that Air Force Academy Cadet 3rd Class Hunter Brown died of a blood clot in his lungs that was caused by an injury to his left foot that he sustained during football practice weeks earlier, according to a copy of Brown’s autopsy report that was provided to Task & Purpose.”
The final diagnosis also noted enlarged liver, heart, and spleen for Brown, a Louisiana native who was 6-foot-3 and 292 pounds at the time of his death at the at the age of 21.” [https://gazette.com/sports/autopsy-for-air-force-football-player-hunter-brown-released/article_05da22d4-a242–11ed-88b1-b767cb0e502b.html]
Cadet Brown had a fracture dislocation of the base of his second toe that was repaired surgically. Blood clots (superficial or deep venous thrombosis) following surgery for an injury of this type are exceedingly rare and, when they occur, they seldom break free and travel to the lung (pulmonary embolus).
Selby, Rita MBBS, FRCPC, MSc*,†; Geerts, William H. MD*; Kreder, Hans J. MD, MSc‡; Crowther, Mark A. MD, MSc§; Kaus, Lisa*; Sealey, Faith RN*. A Double-Blind, Randomized Controlled Trial of the Prevention of Clinically Important Venous Thromboembolism After Isolated Lower Leg Fractures. Journal of Orthopaedic Trauma 29(5):p 224–230, May 2015. | DOI: 10.1097/BOT.000000000000025
The primary effectiveness outcome was clinically important venous thromboembolism (CIVTE), defined as the composite of symptomatic venous thromboembolism within 3 months after surgery and asymptomatic proximal deep vein thrombosis on DUS. The primary safety outcome was major bleeding.
Two hundred fifty-eight patients (97%) were included in the primary outcome analysis for effectiveness (130: dalteparin; 128: placebo). Incidence of CIVTE in the dalteparin and placebo groups was 1.5% and 2.3%, respectively (absolute risk reduction, 0.8%; 95% confidence interval, −2.0 to 3.0).
There were no fatal pulmonary emboli or major bleeding. (https://pubmed.ncbi.nlm.nih.gov/25900749/)
Assuming Hunter Brown had an extremely unlikely fatal pulmonary embolus, such an event is sudden and catastrophic with no time to develop associated pathology in the liver, heart, and spleen.
Hunter Brown’s medical event and the associated autopsy findings do have an excellent match with the pattern of organ damage from Spike-producing therapeutic agents (SPTA). In a report (following) of what the authors believe was the first autopsy in a Spike-producing therapeutic associated fatality, nine different organs or tissues were damaged by the LNP/mRNA.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8051011/pdf/main.pdf
Conclusions from Drs. Bhakdi and Burkhardt
• “Histopathologic analyses show clear evidence of vaccine-induced, autoimmune-like pathology in multiple organs.
• That myriad adverse events deriving from such auto-attack processes must be expected to very frequently occur in all [COVID-vaccinated] individuals, particularly following booster injections.
• Beyond any doubt, injection of gene-based COVID-19 vaccines place lives under threat of illness and death.
• We note that both mRNA and vector-based vaccines are represented among these cases, as are all four major manufacturers.”
(Bhakdi and Burkhardt, “On COVID vaccines: why they cannot work, and irrefutable evidence of their causative role in deaths after vaccination.” Transcript from Live Streamed presentations at the Doctors for COVID Ethics Symposium December 10, 2021. https://doctors4covidethics.org/on-covid-vaccines-why-they-cannot-work-and-irrefutable-evidence-of-their-causative-role-in-deaths-after-vaccination/)
Six: “542 Neurological Adverse Events, 95% Serious, in First 90 Days of Pfizer mRNA Vaccine Rollout. 16 Deaths. Females Suffered AEs More Than Twice As Often As Males.”
—Joseph Gehrett, MD; Barbara Gehrett, MD; Chris Flowers, MD; and Loree Britt
The WarRoom/DailyClout Pfizer Documents Analysis Project Post-Marketing Group (Team 1)—Barbara Gehrett, MD; Joseph Gehrett, MD; Chris Flowers, MD; and Loree Britt—produced an alarming review of the neurological System Organ Class (SOC) adverse events found in Pfizer document 5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-FEB-2021 (a.k.a., “5.3.6”). This SOC includes altered function of the brain, spinal cord, or peripheral nerves.
It is important to note that the adverse events (AEs) in the 5.3.6 document were reported to Pfizer for only a 90-day period starting on December 1, 2020, the date of the United Kingdom’s public rollout of Pfizer’s COVID-19 experimental mRNA “vaccine” product.
Key points in this report include:
• 542 neurological events, 95% of which were serious, occurred in 501 patients.
• 16 patients died.
• 50% of events occurred within the first 24 hours after injection, equating to over 270 events in a single day.
• 69% of the neurological events affected females, and 31% occurred in males.
• 376 seizures were reported, twelve of which were “status epilepticus,” a rare condition of prolonged seizure or series of seizures that is life-threatening.
• 38 cases of multiple sclerosis.
• 11 cases of transverse myelitis (a destructive inflammation of the spinal cord).
• 10 cases of optic neuritis (inflammation of the optic nerve threatening blindness).
• 24 cases of Guillain-Barré syndrome, ascending paralysis from nerve inflammation.
• Three cases of meningitis (infection and inflammation of the fluid and membranes surrounding the brain and spinal cord).
• Seven cases of encephalopathy (any disease of the brain that alters brain function or structure; hallmark is altered mental state).
• Only adverse events that occurred two or more times are specifically reported in the diagnoses list. There were twenty events that happened once and, thus, were not included.
Seven: “Part 2—‘Autopsies Reveal Medical Atrocities of Genetic Therapies Being Used Against a Respiratory Virus’”
—Robert W. Chandler, MD, MBA; Michael Palmer, MD
Histopathological reevaluation of serious adverse events and deaths following COVID-19 vaccination
Professor Arne Burkhardt
Pathologist
Reutlingen, Germany
Professor Dr. Arne Burkhardt gave an update on his series of autopsy and biopsy cases associated with Spike associated gene therapy entitled “Histopathological reevaluation of serious adverse events and deaths following COVID-19 vaccination” at the January 2023 Pandemic Strategies: Lessons and Strategies conference in Stockholm Sweden, presented by the Swedish physician group Läkaruppropet. (The Doctors’ Call) https://lakaruppropet.se/
[Note: A rough draft was prepared using voice recognition then was edited for clarity with an effort to retain Professor Dr. Burkhardt’s original meaning. The text was then added to the presentation graphics. Text in italics has been added by the current author.]
Arne Burkhardt, Professor and MD of Pathology studied Medicine at the Universities of Kiel, Munich and Heidelberg. He trained in Pathology at the Universities of Heidelberg and Hamburg (1970–1979) and became Professor of Pathology at the Universities of Hamburg (1979) and Tübingen (1991). He holds a position as an Extraordinarius Emeritus for General and Special Pathology at the University of Bern, Switzerland, and has been practicing as a pathologist in his own laboratory since 2008. Dr. Burkhardt has held guest professorships in numerous universities in the United States (Harvard, Brookhaven), Japan (Nihon), South Korea, and Europe. He has authored more than 150 original publications in international and German medical journals and contributed to textbooks in German, English, and Japanese.
Summary
The Burkhardt Group (TBG) now consists of a 10-member international research team of pathologists, coroners, biologists, chemists, and physicists.
TBG now has 100 autopsy and 20 biopsy cases in various stages of analysis, 51 of which are the subject of this report.
There were 26 men and 25 women; ages ranged from 21 to 94.
Death occurred from seven days to six months after the last injection of Spike-mediated gene therapy. The larger series had one case in which death occurred eight months after the last gene therapy injection.
The deceased received Spike-inducing drugs from four manufacturers: Janssen/Johnson and Johnson, Pfizer/BioNTech, Moderna, and AstraZeneca.
Initial autopsy reports listed cause of death as or “natural” or uncertain in 49/51 cases.
Evaluation consisted of Histology, Special Stains, Immunochemistry, and Advanced physicochemical methods.
Forensic autopsy disclosed that the cause of death at a highly likely or likely level of probability (to a reasonable degree of medical probability) was from Spike-inducing gene therapy products in 80% of cases.
Findings:
[SET I., II., III. lists, + numbered lists below each]
I. General Lesions affecting more than one organ were characterized by:
1. Presence of Spike protein and absence of nucleocapsid protein (SARS-CoV-2 only).
2. Both arterial and venous systems had inflammation of the inner lining of the blood vessel wall.
3. Larger vessels had evidence of inflammation in the elastic fibers of the aorta and larger vessels.
4. Crystals consistent with cholesterol were identified in remote tissues and were thought to have been released from atheromata that were unroofed after the inner arterial lining were disrupted by Spike-caused erosion of the endothelium releasing debris and cholesterol emboli.
5. Abnormal proteinaceous material consistent with amyloid was identified in multiple tissues.
6. Unusual and aggressive cancer was identified and labelled “Turbo Cancer.”
7. Atypical “clot” formation was identified.
8. “True” foreign bodies from contaminated vaccine were identified.
II. Specific Organ and Tissue Lesions involving the vascular system were characterized by:
Small Vessels:
1. Heart, lung, and brain had evidence of inflammation of the inner wall of blood vessels (endotheliitis).
2. Evidence of bleeding (hemorrhage).
3. Unusual blood clot formation comprised of amyloid, spike protein, and fibrin.
4. Presence of small blood clots and clot-forming blood cells.
5. Obliteration of blood vessels.
Large Vessels:
1. Disrupted blood vessel wall of the aorta with associated lymphocytic vasculitis and perivasculitis.
2. Damage to the inner lining of blood vessels with “unroofing” of cholesterol filled plaque.
3. Disruption of the inner lining of blood vessels with dissection into the muscular middle layer of major arteries and subsequent dissection and aneurysm formation.
4. Full thickness disruption of the aorta with exsanguination.
5. Thrombotic casts.
III. Main Pathologic Findings (other organs) were characterized by:
1. Myocarditis— lymphocytic infiltration
with/without destruction of muscle fibers
scar formation
2. Alveolitis— diffuse alveolar damage (DAD)
lymphocytic interstitial pneumonia endogen-allergic?
3. Lymphocytic nodules outside lymphatic organs
association with autoimmune diseases
Lymphocyte—Amok
Dr. Burkhardt: I have to tell you how it all started. . . .
Soon after the first vaccinations were done in Germany, I was approached by relatives whose loved ones had died suddenly after the vaccination. They were autopsied, and the pathologist said, “Well, it’s all natural causes.” The loved ones didn’t believe it. So, they went to other pathologists. They declined to look at these slides. And I was approached if I could give a second opinion.
And I said, “Well, of course I’ve done this in 40 years of pathology practice, and I will do it.” After the first five cases, I realized that this was not an easy task and that it had to change from a second opinion to a scientific project. First of all, I was alone, then joined by Professor Dr. Lang of the University of Hannover. He’s also an experienced pathologist.
We started to look many times at these specimens that were sent to us, and which had come from the autopsies done by other pathologists. Now we are all in all 10 pathologists, coroners, biologists, chemists, and physicists that have joined to elucidate these cases.
I have to remind you that this is an ongoing examination. In the tables that will follow, I have different collectives because I cannot update every time I give a lecture.
In August 22 (previous studies’ summary) we had:
• 51 deceased and four living persons that we examined. (As of January 2023, we have 100 autopsies and 20 biopsies.)
• Of the 51 deceased, we had 26 men and 25 women.
• Age range: 21 to 94.
• Death occurred seven days to six months after the recent injection.
The vaccines are the ones that are usually in Germany. The task was to see if the vaccination had anything to do with the death occurrence.
Among 51 cases:
• 22 cases were autopsies by coroners and usually without histology.
• 20 cases were autopsies by pathologists.
• One case by a pathologist and a coroner.
• In all but two cases the cause of death was reported as “Uncertain” and mostly as “Natural.” Whatever natural death is.
• It was stated the death could be possibly related to vaccination in only in one case.
After looking at all these specimens, histological slides in the microscope, we came to the conclusion that in 80% the vaccination had some influence on the death occurrence.
Death, of course, is a complicated occurrence, especially in an older person. But it may be influenced by vaccination, and there is usually a timely correlation. There’s one other study (below) at Heidelberg University. They said in 30% that death after vaccination is correlated to the vaccination. (Schwab, et al.)
(https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9702955/)
Most of the patients that we examined had a sudden death. They were found at home, on the street, or in the car. So, we don’t have changes caused by treatment like artificial respiration and so on. And of these, 15 of 19, were in the category of what we call now sudden adult death syndrome (SADS). And you may notice this is a new term that has not existed before the vaccination.
What did we do? First of all, we had to realize that there is a difference between the true Corona infection and the vaccination to the body. The Corona infection has protein and other viral antigens like nucleocapsid, while the vaccination only has a spike protein (previous graphic).
So, we have a common denominator. There is an overlap between the true infection and the vaccination; but, in the vaccination, we have other components that might be of relevance to pathological changes like the lipid nanoparticles, mRNA, cholesterol, and, in some cases, contamination, for example, by metals. The later has not been very closely examined until now.
What is the difference between the entry and the primary target of the COVID-19 infection? The true infection goes to the epithelium: eyes, nose, pharynx, airways, and lung. This epithelium is immunocompetent. While, when we inject the vaccine, it goes into the interstitial tissue, into the muscle cells, the endothelium, and usually into the vessels. And these are not immunocompetent.
Now, what are the methods that we used? We used common histology, special stains, immunohistochemistry, and, in some cases, advanced physical chemical methods. From the beginning on, we were aware that this is a special challenge to us, because we don’t have a toxin that is coming from the outside, either by ingestion or by injection.
For example, systemic or histologic demonstration of toxins would not be of any significance; but we had to demonstrate a toxin that the body itself produced, and this was a Spike protein. And that’s why we very soon we developed a method to show the Spike protein in the tissues. (Below)
And we differentiated this from the true infection by demonstrating the nucleocapsid antigen.
General Findings
This is the first part of my presentation—general lesions expect affecting more than one organ.
Now, the first thing that we examined was the expression of Spike protein in the tissue. Then, we found that the endothelium is mostly affected, and there’s a disturbance of vessels generally, especially the larger vessels.
Then we have displaced unidentified vacuolar and crystalline particles, proteinaceous deposits, functional amyloidosis. We have unusual cancer manifestations, and we have clot formations in the blood and, in some cases, true foreign bodies. So, I will show you examples of these.
